RBC Capital analyst Ben Hendrix raised the firm’s price target on Aveanna to $5 from $3 and keeps a Sector Perform rating on the shares after its Q2 earnings beat. The firm is encouraged by the company’s continued execution on both state legislative initiatives and preferred payor arrangements, which support stronger capacity across Aveanna’s platform, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVAH:
- Aveanna Healthcare Shares Investor Presentation Update
- Aveanna Healthcare Shares Crucial Informal Financial Update
- Aveanna raises 2024 revenue view to above $1.985B from above $1.97B
- Aveanna reports Q2 adjusted EPS 1c, consensus (2c)
- Aveanna Announces Second Quarter 2024 Earnings Release Date and Conference Call